title: CK2 protein kinase is stimulated and redistributed by functional herpes simplex virus ICP27 protein.
abstract: It has been shown previously (S. Wadd, H. Bryant, O. Filhol, J. E. Scott, T.-T. Hsieh, R. D. Everett, and J. B. Clements, J. Biol. Chem. 274:28991-28998, 2000) that ICP27, an essential and multifunctional herpes simplex virus type 1 (HSV-1) protein, interacts with CK2 and with heterogeneous ribonucleoprotein K (hnRNP K). CK2 is a pleiotropic and ubiquitous protein kinase, and the tetrameric holoenzyme consists of two catalytic alpha or alpha' subunits and two regulatory beta subunits. We show here that HSV-1 infection stimulates CK2 activity. CK2 stimulation occurs at early times after infection and correlates with redistribution of the holoenzyme from the nucleus to the cytoplasm. Both CK2 stimulation and redistribution require expression and cytoplasmic accumulation of ICP27. In HSV-1-infected cells, CK2 phosphorylates ICP27 and affects its cytoplasmic accumulation while it also phosphorylates hnRNP K, which is not ordinarily phosphorylated by this kinase, suggesting an alteration of hnRNP K activities. This is the first example of CK2 stimulation by a viral protein in vivo, and we propose that it might facilitate the HSV-1 lytic cycle by, for example, regulating trafficking of ICP27 protein and/or viral RNAs.
authors.affiliation: Institute of Virology, University of Glasgow, Scotland, United Kingdom.
authors.forename: Maria D
authors.initials: MD
authors.lastname: Koffa
authors.forename: Joy
authors.initials: J
authors.lastname: Kean
authors.forename: George
authors.initials: G
authors.lastname: Zachos
authors.forename: Stephen A
authors.initials: SA
authors.lastname: Rice
authors.forename: J Barklie
authors.initials: JB
authors.lastname: Clements
mesh_terms: D000818:Animals; D001693:Biological Transport, Active; D047390:Casein Kinase II; D002460:Cell Line; D006224:Cricetinae; D004004:Dichlororibofuranosylbenzimidazole / Q000494:pharmacology; D004789:Enzyme Activation; D004791:Enzyme Inhibitors / Q000494:pharmacology; D018259:Herpesvirus 1, Human / Q000378:metabolism* / Q000472:pathogenicity; D034641:Heterogeneous-Nuclear Ribonucleoprotein K / Q000378:metabolism; D017874:Immediate-Early Proteins / Q000378:metabolism*; D010766:Phosphorylation; D017346:Protein Serine-Threonine Kinases / Q000037:antagonists & inhibitors / Q000378:metabolism*
chemical_list: D004791:Enzyme Inhibitors; D034641:Heterogeneous-Nuclear Ribonucleoprotein K; C057120:ICP27 protein, human herpesvirus 1; D017874:Immediate-Early Proteins; D004004:Dichlororibofuranosylbenzimidazole; D047390:Casein Kinase II; D017346:Protein Serine-Threonine Kinases